Adelene Q Perkins Net Worth & Insider Trades
Adelene Q Perkins - Chief Executive Officer, Infinity Pharmaceuticals, Inc
What is Adelene Q Perkins's Net Worth?
The current estimated net worth of Infinity Pharmaceuticals, Inc's Chief Executive Officer, Adelene Q Perkins, is estimated to be about $3.33M . Adelene Q Perkins owns about 619,643 units of Infinity Pharmaceuticals, Inc common stock. In the last 14 years at Infinity Pharmaceuticals, Inc, Adelene Q Perkins has sold an estimated value of $2.35M worth.
What is Adelene Q Perkins's Past Insider Trading?
Adelene Q Perkins's largest purchase order was 50,000 units , worth over $245.03K on August 26, 2010. Adelene Q Perkins's largest sale order was 45,000 units , worth over $932.49K on September 13, 2013. In total, Adelene Q Perkins has made about 36 transactions over 14 years of their time at Infinity Pharmaceuticals, Inc. Adelene Q Perkins usually trades in January, with the busiest year in 2015. The most recent transaction was a sale order of 5,000 units , worth over $13.89K on March 7, 2018.
Adelene Perkins
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Adelene Q Perkins's Salary in 2020 ?
As Chief Executive Officer of Infinity Pharmaceuticals, Inc, Adelene Q Perkins has a total base salary of $689,585 . Adelene Q Perkins received compensation valued at about $2,743,090 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of stock awards of $193,918 , option awards of $1,399,928 , other earnings, plans or compensations of $448,230 , and other compensation of $11,429 .
What is Adelene Q Perkins's' Mailing Address?
- Mailing address is C/o Infinity Pharmaceuticals, Inc. 780 Memorial Drive Cambridge MA 02139 MA
Infinity Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Adelene Q. Perkins | 2020 | $689,585 | - | $193,918 | $1,399,928 | $448,230 | $11,429 | $2,743,090 |
| Adelene Q. Perkins | 2019 | $689,585 | $61,250 | - | $552,480 | $366,370 | $11,172 | $1,680,857 |
| Lawrence E. Bloch, M.D., J.D. | 2020 | $488,014 | - | $103,946 | $966,961 | $244,007 | $10,425 | $1,813,353 |
| Lawrence E. Bloch, M.D., J.D. | 2019 | $488,014 | - | - | $459,553 | $204,235 | $9,366 | $1,161,168 |
| Seth A. Tasker, J.D | 2020 | $386,159 | - | $66,923 | $818,913 | $154,463 | $8,986 | $1,435,444 |
| Seth A. Tasker, J.D | 2019 | $367,770 | - | - | $138,012 | $138,330 | $8,820 | $652,932 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1113148/000114036121014200/nc10021449x1_def14a.htm
What are Infinity Pharmaceuticals, Inc's Past Insider Trades?
Infinity Pharmaceuticals, Inc's most recent insider trade came on August 4, 2022 by Stephane Peluso who bought 64,994 units worth $9.93K . In the last 15 years, insiders at Infinity Pharmaceuticals, Inc have sold an estimated value of $486.71M and bought an estimated value of $209.8M worth of shares. Insider trading is most common in January, with the busiest year in 2012. The most active traders at the company are Adelene Perkins, Chief Executive Officer, Anthony B Evnin, and Michael Venuti, Director .
INFINITY PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||